Antioxidant and hepatoprotective effects of Korean ginseng extract GS-KG9 in a D-galactosamine-induced liver damage animal model

  • Received : 2020.02.12
  • Accepted : 2020.03.24
  • Published : 2020.08.01


BACKGROUND/OBJECTIVES: This study was designed to investigate the improvement effect of white ginseng extract (GS-KG9) on D-galactosamine (Ga1N)-induced oxidative stress and liver injury. SUBJECTS/METHODS: Sixty Sprague-Dawley rats were divided into 6 groups. Rats were orally administrated with GS-KG9 (300, 500, or 700 mg/kg) or silymarin (25 mg/kg) for 2 weeks. The rats of the GS-KG9- and silymarin-treated groups and a control group were then intraperitoneally injected Ga1N at a concentration of 650 mg/kg for 4 days. To investigate the protective effect of GS-KG9 against GalN-induced liver injury, blood liver function indicators, anti-oxidative stress indicators, and histopathological features were analyzed. RESULTS: Serum biochemical analysis indicated that GS-KG9 ameliorated the elevation of aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), and lactate dehydrogenase (LDH) in GalN-treated rats. The hepatoprotective effects of GS-KG9 involved enhancing components of the hepatic antioxidant defense system, including glutathione, glutathione peroxidase (GPx), superoxide dismutase (SOD), and catalase (CAT). In addition, GS-KG9 treatment inhibited reactive oxygen species (ROS) production induced by GalN treatment in hepatocytes and significantly increased the expression levels of nuclear factor erythroid-2-related factor 2 (Nrf2) and heme oxygenase-1 (HO-1) proteins, which are antioxidant proteins. In particular, by histological analyses bases on hematoxylin and eosin, Masson's trichrome, α-smooth muscle actin, and transforming growth factor-β1 staining, we determined that the administration of 500 mg/kg GS-KG9 inhibited hepatic inflammation and fibrosis due to the excessive accumulation of collagen. CONCLUSIONS: These findings demonstrate that GS-KG9 improves GalN-induced liver inflammation, necrosis, and fibrosis by attenuating oxidative stress. Therefore, GS-KG9 may be considered a useful candidate in the development of a natural preventive agent against liver injury.


  1. Jaeschke H, Gores GJ, Cederbaum AI, Hinson JA, Pessayre D, Lemasters JJ. Mechanisms of hepatotoxicity. Toxicol Sci 2002;65:166-76.
  2. Patel T, Roberts LR, Jones BA, Gores GJ. Dysregulation of apoptosis as a mechanism of liver disease: an overview. Semin Liver Dis 1998;18:105-14.
  3. Li S, Tan HY, Wang N, Zhang ZJ, Lao L, Wong CW, Feng Y. The role of oxidative stress and antioxidants in liver diseases. Int J Mol Sci 2015;16:26087-124.
  4. Aube C, Bazeries P, Lebigot J, Cartier V, Boursier J. Liver fibrosis, cirrhosis, and cirrhosis-related nodules: Imaging diagnosis and surveillance. Diagn Interv Imaging 2017;98:455-68.
  5. Hong IH, Park SJ, Goo MJ, Lee HR, Park JK, Ki MR, Kim SH, Lee EM, Kim AY, Jeong KS. JNK1 and JNK2 regulate ${\alpha}$-SMA in hepatic stellate cells during CCl4 -induced fibrosis in the rat liver. Pathol Int 2013;63:483-91.
  6. Keppler D, Decker K. Studies on the mechanism of galactosamine-1-phosphate and its inhibition of UDPglucose pyrophosphorylase. Eur J Biochem 1969;10:219-25.
  7. Pushpavalli G, Kalaiarasi P, Veeramani C, Pugalendi KV. Effect of chrysin on hepatoprotective and antioxidant status in D-galactosamine-induced hepatitis in rats. Eur J Pharmacol 2010;631:36-41.
  8. Choi KT. Botanical characteristics, pharmacological effects and medicinal components of Korean Panax ginseng C A Meyer. Acta Pharmacol Sin 2008;29:1109-18.
  9. Shin MS, Song JH, Choi P, Lee JH, Kim SY, Shin KS, Ham J, Kang KS. Stimulation of innate immune function by Panax ginseng after heat processing. J Agric Food Chem 2018;66:4652-9.
  10. Choi JG, Kim N, Huh E, Lee H, Oh MH, Park JD, Pyo MK, Oh MS. White ginseng protects mouse hippocampal cells against amyloid-beta oligomer toxicity. Phytother Res 2017;31:497-506.
  11. Liu Z, Li Y, Li X, Ruan CC, Wang LJ, Sun GZ. The effects of dynamic changes of malonyl ginsenosides on evaluation and quality control of Panax ginseng C.A. Meyer. J Pharm Biomed Anal 2012;64-65:56-63.
  12. Du XW, Wills RB, Stuart DL. Changes in neutral and malonyl ginsenosides in American ginseng (Panax quinquefolium) during drying, storage and ethanolic extraction. Food Chem 2004;86:155-9.
  13. Liu Z, Li W, Li X, Zhang M, Chen L, Zheng YN, Sun GZ, Ruan CC. Antidiabetic effects of malonyl ginsenosides from Panax ginseng on type 2 diabetic rats induced by high-fat diet and streptozotocin. J Ethnopharmacol 2013;145:233-40.
  14. Oh MH, Park YS, Lee H, Kim NY, Jang YB, Park JH, Kwak JY, Park YS, Park JD, Pyo MK. Comparison of physicochemical properties and malonyl ginsenoside contents between white and red ginseng. Korean J Pharmacogn 2016;47:84-91.
  15. Lu KH, Weng CY, Chen WC, Sheen LY. Ginseng essence, a medicinal and edible herbal formulation, ameliorates carbon tetrachloride-induced oxidative stress and liver injury in rats. J Ginseng Res 2017;41:316-25.
  16. Kim MH, Lee EJ, Cheon JM, Nam KJ, Oh TH, Kim KS. Antioxidant and hepatoprotective effects of fermented red ginseng against high fat diet-induced hyperlipidemia in rats. Lab Anim Res 2016;32:217-23.
  17. Wang W, Wang S, Liu J, Cai E, Zhu H, He Z, Gao Y, Li P, Zhao Y. Sesquiterpenoids from the root of Panax ginseng protect $CCl_{4}$-induced acute liver injury by anti-inflammatory and anti-oxidative capabilities in mice. Biomed Pharmacother 2018;102:412-9.
  18. Niranjana Murthy H, Dandin VS, Yoeup Paek K. Hepatoprotective activity of ginsenosides from Panax ginseng adventitious roots against carbon tetrachloride treated hepatic injury in rats. J Ethnopharmacol 2014;158 Pt A:442-6.
  19. McGill MR. The past and present of serum aminotransferases and the future of liver injury biomarkers. EXCLI J 2016.15:817-28.
  20. Sarac F, Saygili F. Causes of high bone alkaline phosphatase. Biotechnol Biotechnol Equip 2007;21:194-7.
  21. Chaudhary A, Chauhan V. Lactate dehydrogenase as an indicator of liver diseases. J Adv Med Dent Sci Res 2015;3:S20-2.
  22. Ighodaro OM, Akinloye OA. First line defence antioxidants-superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPX): Their fundamental role in the entire antioxidant defence grid. Alexandria J Med 2018;54:287-93.
  23. Hu HL, Chen RD. Changes in free radicals, trace elements, and neurophysiological function in rats with liver damage induced by D-galactosamine. Biol Trace Elem Res 1992;34:19-25.
  24. Parthasarathi S, Hong SC, Oh MH, Park YS, Yoo JH, Seol SY, Lee H, Park JD, Pyo MK. Anti-oxidant and hepatoprotective effect of white ginsengs in H2O2-treated HepG2 cells. Nat Prod Sci 2015;21:210-8.
  25. Kemelo MK, Horinek A, Canova NK, Farghali H. Comparative effects of Quercetin and SRT1720 against D-galactosamine/lipopolysaccharide-induced hepatotoxicity in rats: biochemical and molecular biological investigations. Eur Rev Med Pharmacol Sci 2016;20:363-71.
  26. Choi JW, Kim IH, Kim YM, Lee MK, Nam TJ. Pyropia yezoensis glycoprotein regulates antioxidant status and prevents hepatotoxicity in a rat model of D-galactosamine/lipopolysaccharide-induced acute liver failure. Mol Med Rep 2016;13:3110-4.
  27. Takahashi T, Morita K, Akagi R, Sassa S. Heme oxygenase-1: a novel therapeutic target in oxidative tissue injuries. Curr Med Chem 2004;11:1545-61.
  28. Tian Y, Li Z, Shen B, Wu L, Han L, Zhang Q, Feng H. The protective effects of Shikonin on lipopolysaccharide/D-galactosamine-induced acute liver injury via inhibiting MAPK and $NF-{\kappa}B$ and activating Nrf2/HO-1 signaling pathways. RSC Advances 2017;7:34846-56.
  29. Ma Q. Role of Nrf2 in oxidative stress and toxicity. Annu Rev Pharmacol Toxicol 2013;53:401-26.
  30. Guyot C, Lepreux S, Combe C, Doudnikoff E, Bioulac-Sage P, Balabaud C, Desmouliere A. Hepatic fibrosis and cirrhosis: the (myo)fibroblastic cell subpopulations involved. Int J Biochem Cell Biol 2006.38:135-51.
  31. Bataller R, Brenner DA. Liver fibrosis. J Clin Invest 2005;115:209-18.
  32. Tomanovic NR, Boricic IV, Brasanac DC, Stojsic ZM, Delic DS, Brmbolic BJ. Activated liver stellate cells in chronic viral C hepatitis: histopathological and immunohistochemical study. J Gastrointestin Liver Dis 2009;18:163-7.
  33. Liu RM, Desai LP. Reciprocal regulation of TGF-${\beta}$ and reactive oxygen species: A perverse cycle for fibrosis. Redox Biol 2015;6:565-77.
  34. Meng XM, Nikolic-Paterson DJ, Lan HY. TGF-${\beta}$: the master regulator of fibrosis. Nat Rev Nephrol 2016;12:325-38.